These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination. Brain MC; Ruether B; Valentine K; Brown C; ter Keurs H Transfusion; 2010 Feb; 50(2):292-301. PubMed ID: 19843291 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia. Tremblay T; Paré I; Bazin R Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706 [TBL] [Abstract][Full Text] [Related]
5. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927 [TBL] [Abstract][Full Text] [Related]
6. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcγ receptors in a murine model. Liepkalns JS; Hod EA; Stowell SR; Cadwell CM; Spitalnik SL; Zimring JC Transfusion; 2012 Dec; 52(12):2631-45. PubMed ID: 22502635 [TBL] [Abstract][Full Text] [Related]
7. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455 [TBL] [Abstract][Full Text] [Related]
8. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells. Bazin R; Lemieux R; Tremblay T; St-Amour I Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982 [TBL] [Abstract][Full Text] [Related]
9. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Blanchette VS; Kirby MA; Turner C Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia. Deng R; Balthasar JP Blood; 2007 Mar; 109(6):2470-6. PubMed ID: 17132715 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura. Jin F; Balthasar JP Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704 [TBL] [Abstract][Full Text] [Related]
16. Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg). Damianovich M; Blank M; Raiter A; Hardy B; Shoenfeld Y Int Immunol; 2009 Sep; 21(9):1057-63. PubMed ID: 19625382 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090 [TBL] [Abstract][Full Text] [Related]
18. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Win N; Sinha S; Lee E; Mills W Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: A multicenter study. Marsalli G; Nastasio S; Sciveres M; Calvo PL; Ramenghi U; Gatti S; Albano V; Lega S; Ventura A; Maggiore G Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):83-9. PubMed ID: 26138133 [TBL] [Abstract][Full Text] [Related]